News of Note - March 3-4, 2023
BULL BEAR BRES|NAHAN
Saturday, March 4, 2023
As of --> 09:10 EET
Programming update, the next week or two will see a pause in this, I know, we only just restarted sending stuff out into the ether.. Personal/ family business to tend to.. See you on the other side..
In healthcare land you're seeing pharma start to push back, could get interesting out there; seems they're not in the mood to be pushed around any longer..
As Art Cashin says, stay nimble..
And let me add, don’t whipsaw yourself!!
Keros Therapeutics [bio]
Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results
Eli Lilly [cc: PFE & NOVN SW | NVS]
U.S. FDA Broadens Indication for Verzenio® (abemaciclib) in HR+, HER2-, Node-Positive, High Risk Early Breast Cancer
Bristol Myers Squibb
Receives European Commission Approval of Reblozyl® (luspatercept) for Anemia in Adult Patients with Non-Transfusion-Dependent Beta Thalassemia
Third authorized indication in Europe for Reblozyl, a first-in-class treatment for patients with diseases impacted by anemia
Verve Therapeutics [bio]
Reports New Preclinical Data Demonstrating Potent and Durable Editing of ANGPTL3 Gene with VERVE-201 in Wild-type and LDLR-deficient Non-Human Primates
Receives Carl-Gustaf Ammunition Order from Lithuania
Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma
EQNR NO | EQNR
ERICA SS | ERICB SS | ERIC
U.S. Department of Justice Resolves 2019 Deferred Prosecution Agreement Breaches with Ericsson
Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Huntington Ingalls Industries
HII and Ocean Aero to Partner on Advanced Unmanned Maritime Capabilities
ILMN & MYGN
Illumina & Myriad Genetics
Expand partnership to broaden access to HRD testing in the United States
Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry
AZN SS | AZN LN | AZN & MRK
AstraZeneca & Merck
Update on US regulatory review of Lynparza in combination with abiraterone for mCRPC
PHIA NA | PHG
Koninklijke (Royal) Philips
Showcases comprehensive cardiology portfolio designed to increase physician confidence and efficiency in diagnosing and treating cardiac disease at ACC/WCC 2023
Advantus Health Partners and GE HealthCare Announce Multi-Year Agreement to Expand Access to Healthcare Technology Management Services
The two companies will offer healthcare organizations a holistic program that goes beyond the traditional break-fix approach to medical device maintenance
Advantus Health Partners will leverage the expanded relationship to support quality care and sustainable cost reductions for its clients
Matinas BioPharma [bio]
Announces that MAT2203 Will Be Featured in Two Oral Presentations at ECCMID
BMY & JNJ
Bristol Myers Squibb & Janssen (J&J)
Collaboration Launches Pivotal Phase 3 Librexia Clinical Trial Program Evaluating Milvexian, an Investigational Oral Factor XIa Inhibitor
Verve Therapeutics [bio]
Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
MOR GY | MOR
Stops Work and Operations on Pre-Clinical Research Programs
UK and pharma (generic and branded) going to war..
UK government plans to hike revenue clawback rates beginning in April
Roche, Exelixis' Tecentriq/Cabometyx combo flunks second PhIII
Pablo Escobar’s ‘cocaine hippos’ spark conservation row
Researchers worry Colombian environment ministry will side with animal-rights activists rather than curb the invasive animals’ spread.
What Now for a Fed That Has Fallen Behind the Curve Again?
The central bank downshifted rate increases too early and now faces a set of dilemmas and another knock to its credibility. - El-Erian
Who Owns Train Cars? Hint: Usually Not the Railroad
Private owners such as shippers and lessors account for about two-thirds of the cars operating on North American tracks, and maintenance obligations typically fall to them.
Blackstone Defaults on Nordic CMBS as Property Values Wobble
The notes are backed by a portfolio of offices and stores
Blackstone has been trying to sell the underlying properties
Toblerone Is Barred From Using the Iconic Swiss Mountain on Its Logo
Big Food Brands Struggling to Kick Junk Addiction, Survey Finds
Kraft Heinz, Nestle, Unilever, Kellogg rely on unhealthy food
Over 2,000 items sold in Australia, France, Mexico analyzed
Taylor Swift Boosts Universal Music’s Sales to $3.1 Billion
Universal Music Group’s sales rose 17% in the fourth quarter
Swift’s “Midnights” album sold over 6 million in eight weeks
Ancient DNA upends European prehistory
Genes reveal striking diversity within similar ice age cultures
Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.
Viatris warns it will stop selling essential drugs in UK without changes to drug pricing agreement
AstraZeneca, Merck's Lynparza to face FDA panel in prostate cancer bid as PARP scrutiny escalates
Obesity's global toll heads toward $4 trillion a year
How meningitis-causing bacteria invade the brain
Experiments in mice show the microbes hijack cells in the brain’s protective cover
Here’s how lemon juice may fend off kidney stones
Nanoparticles in the juice slowed the formation of the stones in rats
The sun sets on Exelixis’s pipeline in a product
After Cabometyx’s latest clinical setback Exelixis might have to turn to follow-on projects for future growth.
Spotlight – What is next in Nash
The next few months will see some important mid-stage Nash results, from Viking, 89Bio, Northsea and others.
GSK gets the vaccine edge on Pfizer
US experts favour GSK’s RSV vaccine over Pfizer’s, but both could be on the market soon.